These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2028446)

  • 1. Degradation of a benzamidine-type synthetic inhibitor of coagulation enzymes in plasma of various species.
    Hauptmann J
    Thromb Res; 1991 Feb; 61(3):279-84. PubMed ID: 2028446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine.
    Stürzebecher J; Prasa D; Wikström P; Vieweg H
    J Enzyme Inhib; 1995; 9(1):87-99. PubMed ID: 8568569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
    Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
    J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine.
    Stürzebecher J; Prasa D; Hauptmann J; Vieweg H; Wikström P
    J Med Chem; 1997 Sep; 40(19):3091-9. PubMed ID: 9301673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic inhibitors of bovine factor Xa and thrombin comparison of their anticoagulant efficiency.
    Stürzebecher J; Stürzebecher U; Vieweg H; Wagner G; Hauptmann J; Markwardt F
    Thromb Res; 1989 May; 54(3):245-52. PubMed ID: 2749616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
    Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
    J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of a novel synthetic NAPAP-penta-saccharide conjugate displaying a dual antithrombotic action.
    Buijsman RC; Basten JE; van Dinther TG; van der Marel GA; van Boeckel CA; van Boom JH
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2013-8. PubMed ID: 10450972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of new NAPAP-analogs.
    Steinmetzer T; Schweinitz A; Künzel S; Wikström P; Hauptmann J; Stürzebecher J
    J Enzyme Inhib Med Chem; 2002 Apr; 17(2):241-9. PubMed ID: 12420761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
    Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
    J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary excretion of synthetic benzamidine-type thrombin inhibitors in rabbits and rats.
    Hauptmann J; Kaiser B; Paintz M; Markwardt F
    Biomed Biochim Acta; 1987; 46(6):445-53. PubMed ID: 3675563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies on the antithrombotic action of a highly effective synthetic thrombin inhibitor.
    Kaiser B; Markwardt F
    Thromb Haemost; 1986 Apr; 55(2):194-6. PubMed ID: 3814237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts on action of synthetic thrombin inhibitors.
    Geratz JD; Tidwell RR
    Haemostasis; 1978; 7(2-3):170-6. PubMed ID: 350730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
    Zhou Y; Johnson ME
    J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of thrombin with benzamidine-based inhibitors.
    Stürzebecher J; Vieweg H; Wikström P; Turk D; Bode W
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):491-6. PubMed ID: 1515080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thrombin generation in plasma by inhibitors of factor Xa.
    Prasa D; Svendsen L; Stürzebecher J
    Thromb Haemost; 1997 Oct; 78(4):1215-20. PubMed ID: 9364987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of a new structural variant of 4-amidinophenylalanine amide-type synthetic thrombin inhibitor.
    Hauptmann J; Kaiser B; Paintz M; Markwardt F
    Pharmazie; 1989 Apr; 44(4):282-4. PubMed ID: 2772004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of benzamidine-type thrombin inhibitors.
    Hauptmann J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):89-97. PubMed ID: 6177614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
    Bode W; Turk D; Stürzebecher J
    Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel plasma kallikrein inhibitors of the benzamidine type.
    Stürzebecher J; Prasa D; Wikström P; Vieweg H
    Braz J Med Biol Res; 1994 Aug; 27(8):1929-34. PubMed ID: 7749383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factor Xa in vitro and in vivo.
    Hayashi M; Hamada A; Okaya Y; Wakitani K; Aisaka K
    Eur J Pharmacol; 2001 Oct; 428(2):163-8. PubMed ID: 11675032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.